U.S. market Closed. Opens in 16 minutes

PRAX | Praxis Precision Medicines, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue2.45MN/AN/AN/AN/AN/A
Cost of Revenue432.00K1.17M1.59M746.00K679.00KN/A
Gross Profit2.02M-1.17M-1.59M-746.00K-679.00KN/A
Operating Expenses128.82M214.99M167.33M61.97M35.79M22.72M
Selling, General & Admin42.05M59.95M47.08M16.99M6.23M3.90M
Research & Development86.77M155.04M120.26M44.98M29.56M18.82M
Other Operating Expenses3.10M957.00K271.00K140.00KN/A-3.65M
Operating Income-126.37M-214.99M-167.33M-61.97M-35.79M-22.72M
Other Expenses / Income3.10M957.00K271.00K140.00K193.00K-3.65M
Before Tax Income-123.28M-214.03M-167.06M-61.83M-35.60M-26.40M
Income Tax Expenses264.11K-957.00K-182.00K-8.00K-84.00K133.00K
Net Income-123.28M-213.07M-166.88M-61.82M-35.51M-26.54M
Interest ExpensesN/A-419.00KN/AN/AN/A127.00K
Basic Shares Outstanding6.59M3.07M2.83M596.68K101.97K13.27M
Diluted Shares Outstanding6.59M3.07M2.83M596.68K101.97K13.27M
EBITDA-125.94M-214.99M-167.33M-61.97M-35.56M-26.27M
EBITDA Margin-5,146.75%0.00%0.00%0.00%0.00%0.00%
EBIT-123.01M-214.45M-167.06M-61.83M-35.60M-26.27M
EBIT Margin-5,027.09%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙